{调取该文章的TAG关键词}|The Hyaluronan Market, A New Found Gold Mine in China( 三 ) {调取该文章的TAG关键词}

The top three hyaluronic acid players in ChinaImeik Technology, Haohai Biological Technology, and Bloomage BioTechnology have distinct business operations. Imeik Technology focuses on hyaluronan injection for cosmetic procedures, while Haohai Biological Technology is dedicated to hyaluronan for orthopedics and ophthalmology. Bloomage BioTechnology on the other hand pays attention to hyaluronan raw material supply, skincare products, and cosmetics medicine. In 2021, Bloomage BioTechnology started to work on edible hyaluronan products.
Since its public listing in September 2020, Imeik Technology has been attracting massive attention with its hyaluronan injection products. The company currently has five hyaluronan product lines and a thread lift product, all of which have received medical equipment qualifications. Imeik's hearty is the only medical equipment approved by the National Medical Products Administration that is designed to smoothen neck wrinkles. The lack of similar products in the industry has made Hearty an ultra-successful product for Imeik.
"Imeik is an unprecedented product because it is very exclusive and has technological barriers, while other similar products have not yet received a qualification from the authority," said Gong Liansheng, founder of Meibei, a cosmetic product, and procedure e-commerce platform. Gong believes that products without any technological barrier will have their prices dropping very fast.
Bloomage BioTechnology is a top player in the hyaluronan skincare sector. Its earliest hyaluronan brand BIOHYALUX failed to gain much success in earlier years due to its low and mid-end positioning. The turning point eventually came as BIOHYALUX's lipstick collaboration with the Forbidden City Museum blew off in 2018. After BIOHYALUX's success, Bloomage BioTechnology rolled out several other skincare brands, including QuadHA, MedRepair, and Bio-MESO. In 2020, Bloomage BioTechnology's skincare business achieved an income of RMB¥1.346 billion.
Besides being a successful skincare brand owner, Bloomage BioTechnology is also the biggest hyaluronan raw material provider in the world. However, its raw material supply business saw a decline in 2020 due to the impact of COVID19. As for the medical sector, Bloomage BioTechnology focuses on orthopedic injection and viscoelastic substances for ophthalmology. The company's medical business has rather slow growth when compared with top player Haohai Biological Technology.
Haohai Biological Technology has never shifted its attention away from the cosmetic medicine sector. However, its brands such as Matrifill that target the low-end market have not been able to gain traction yet. In August last year, Haohai rolled out HYALUMATRIX to penetrate the high-end hyaluronan market.
Bloomage BioTechnology is also seeking new growth points, eyeing the edible hyaluronan market that has a larger scale. The company started to apply for a certificate for edible hyaluronan in 2016 and acquired a company that specializes in edible hyaluronan.
According to Essence Securities' estimates, the sales volume of China's edible hyaluronan raw materials will reach 787 tons in the mid and long term, with the scale of the edible hyaluronan raw material market potentially reaching RMB¥800 million. The sector is expected to bring in revenue growth of RMB¥1.2 billion for Bloomage Biotechnology.

{调取该文章的TAG关键词}|The Hyaluronan Market, A New Found Gold Mine in China( 三 )

推荐阅读

弥鹿32合1桌游质量好吗？弥鹿32合1桌游怎么样

私人借贷合法吗？私人借贷风险大不大？

小米手机锁屏密码忘记了怎么办

C罗无缘金球奖，球迷大呼“我不服！”

spring|spring security 之自定义表单登录源码跟踪

老板脉冲点火接触不良：原因了解及解决方法

士惠628玉米种特征产量，附简介玉米新品种士惠628介绍

绒毯属于什么垃圾

go语言计算题，C语言计算题

适合男人的微信名称男人微信起名大全

pr倒放视频还原教程分享

什么咳嗽可以喝大蒜煮水

go语言写java后端 go语言前端还是后端

量化招聘（项目经理（IT)）

团圆饭寓意团圆饭的来历

贝贝南瓜放冰箱能放多久贝贝南瓜可以放冷藏不

降雪分为几个等级

落英缤纷

简短走心的句子成熟有深度的句子

考试没考好怎么办怎么面对家长